ZCMD Stock Overview
Provides healthcare information, education, and training services in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Zhongchao Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.20 |
| 52 Week High | US$9.90 |
| 52 Week Low | US$1.00 |
| Beta | 0.30 |
| 11 Month Change | -21.67% |
| 3 Month Change | -8.40% |
| 1 Year Change | -87.37% |
| 33 Year Change | -93.65% |
| 5 Year Change | n/a |
| Change since IPO | -97.00% |
Recent News & Updates
Zhongchao Inc.'s (NASDAQ:ZCMD) 32% Dip In Price Shows Sentiment Is Matching Revenues
Nov 15
Zhongchao Inc. (NASDAQ:ZCMD) Surges 76% Yet Its Low P/S Is No Reason For Excitement
Oct 01Recent updates
Zhongchao Inc.'s (NASDAQ:ZCMD) 32% Dip In Price Shows Sentiment Is Matching Revenues
Nov 15Zhongchao Inc. (NASDAQ:ZCMD) Surges 76% Yet Its Low P/S Is No Reason For Excitement
Oct 01Zhongchao Inc.'s (NASDAQ:ZCMD) Shares Bounce 32% But Its Business Still Trails The Industry
Aug 10Zhongchao Inc.'s (NASDAQ:ZCMD) Shares Bounce 32% But Its Business Still Trails The Industry
Apr 27Benign Growth For Zhongchao Inc. (NASDAQ:ZCMD) Underpins Stock's 30% Plummet
Mar 07Little Excitement Around Zhongchao Inc.'s (NASDAQ:ZCMD) Revenues As Shares Take 50% Pounding
Dec 28Some Investors May Be Worried About Zhongchao's (NASDAQ:ZCMD) Returns On Capital
Apr 14Investors Could Be Concerned With Zhongchao's (NASDAQ:ZCMD) Returns On Capital
Oct 15Zhongchao Inc.: Ask Why?
Sep 21Zhongchao: Cheap Growth And Value Healthcare Education Stock
Jun 29A Piece Of The Puzzle Missing From Zhongchao Inc.'s (NASDAQ:ZCMD) Share Price
May 11Zhongchao reports FY results
Apr 30How Much Did Zhongchao's(NASDAQ:ZCMD) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 23We're Not So Sure You Should Rely on Zhongchao's (NASDAQ:ZCMD) Statutory Earnings
Jan 08
Zhongchao soars 46% on contract renewal by Takeda
Nov 12Shareholder Returns
| ZCMD | US Consumer Services | US Market | |
|---|---|---|---|
| 7D | -0.8% | -5.9% | -2.1% |
| 1Y | -87.4% | 15.3% | 30.2% |
Return vs Industry: ZCMD underperformed the US Consumer Services industry which returned 15.3% over the past year.
Return vs Market: ZCMD underperformed the US Market which returned 30.2% over the past year.
Price Volatility
| ZCMD volatility | |
|---|---|
| ZCMD Average Weekly Movement | 25.4% |
| Consumer Services Industry Average Movement | 9.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZCMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ZCMD's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 142 | James Yang | www.izcmd.com |
Zhongchao Inc. provides healthcare information, education, and training services in the People’s Republic of China. The company offers patient management services in the tumor and rare diseases field; internet healthcare services, and pharmaceutical services, as well as operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content, as well as sells patent drugs.
Zhongchao Inc. Fundamentals Summary
| ZCMD fundamental statistics | |
|---|---|
| Market cap | US$6.90m |
| Earnings (TTM) | -US$6.52m |
| Revenue (TTM) | US$17.41m |
0.4x
P/S Ratio-1.1x
P/E RatioIs ZCMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZCMD income statement (TTM) | |
|---|---|
| Revenue | US$17.41m |
| Cost of Revenue | US$8.48m |
| Gross Profit | US$8.93m |
| Other Expenses | US$15.45m |
| Earnings | -US$6.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.13 |
| Gross Margin | 51.28% |
| Net Profit Margin | -37.48% |
| Debt/Equity Ratio | 0% |
How did ZCMD perform over the long term?
See historical performance and comparison